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Signiﬁcant advances have been made in stem cell research over the past decade. A number of nonhematopoietic sources of stem
cells (or progenitor cells) have been identiﬁed, including endothelial stem cells and neural stem cells. These discoveries have been
a majorstep towardthe use of stem cells forpotential clinical applicationsof organ regeneration. Accordingly, kidney regeneration
is currently gainingconsiderable attentionto replace kidney dialysis as the ultimate therapeutic strategy for renalfailure. However,
due to anatomic complications, the kidney is believed to be the hardest organ to regenerate; it is virtually impossible to imagine
such a complicated organ being completely rebuilt from pluripotent stem cells by gene or chemical manipulation. Nevertheless,
several groups are taking on this big challenge. In this manuscript, current advances in renal stem cell research are reviewed and
their usefulness for kidney regeneration discussed. We also reviewed the current knowledge of the emerging ﬁeld of renal stem cell
biology.
1.Introduction
Recentadvances in stem cell research have brought thepossi-
bility of using somatic stem cells for organ regeneration one
step closer to realization. Newly developed organs can then
beusedinclinicalorganreplacement.However,anatomically
complicated organs such as the kidney have proven more
refractory to stem cell-based regenerative techniques.
The kidney retains the potential to regenerate if the
damage is not too severe, and the kidney structure remains
intact.
It was previously believed that bone marrow-derived
stem cells could diﬀerentiate into renal-resident cells
and participate in kidney regeneration after renal
ischemia/reperfusion injury [1, 2]; however, recent studies
have suggested that the number of bone marrow-derived
cells that engraft injured tubules and developinto functional
renal tissue is very low and, thus, their overall contribution
to renal repair would be minor in the setting of acute
kidney injury [3, 4]. Also, during the progression of chronic
renal failure, bone marrow-derived stem cells supplied
by intravenous administration located in the kidney and
contributed to attenuate renal ﬁbrosis [5]. However, in
cases of irreversible damage to the kidney, as can occur
with long-term dialysis, the kidney structure is totally lost
and, therefore, these cell therapy approach seems not to be
applicable. Thus, any application of regenerative medicine in
end-stage renal disease will require the de novo development
of an entire functional kidney.
In terms of a functional whole kidney, Chan et al. [6]
reported the ﬁrst attempt to develop a functional whole
renal unit by developing a transplantable pronephros in
Xenopus. Xenopus presumptive ectoderm, which becomes
epidermis and neural tissue in normal development, con-
tains pluripotent stem cells and can be diﬀerentiated into
multilineage tissue cells under particular culture conditions
[7]. The researchers designed conditions for the induction
of pronephric tubule-like structures from animal caps that
involved a combination of activin and retinoic acid for
only 3 hours. This pronephros-like tissue was transplanted
into bilaterally nephrectomized tadpoles to test for its func-
tional integrity as a pronephros. Bilateral pronephrectomy
induces severe edema in tadpoles owing to their inability
to excrete internal water, and tadpoles die within 9 days;
transplantation of the pronephros-like unit at least partially
corrected the edema, and tadpoles survived for up to 1
month. To our knowledge, this study is the only one to2 International Journal of Nephrology
develop a transplantable functional whole kidney unit in
vitro, although the pronephros structure formed was too
primitive for any clinical application in humans.
Since then, many attempts have been made worldwide to
regenerate whole kidneysapplicablefor mammals from stem
cells. The present article reviews the challenges and recent
advancesinrenalstemcellresearch anddiscussesitspotential
for clinical application for kidney regeneration in humans.
2.Embryonic KidneyasaSourceof
OrganRegeneration
Woolf et al. [8] reported that the metanephros may continue
to grow if it is transplanted into the renal cortex of
host mice. The developed transplant contains vascularized
glomeruli and mature proximal tubules and may have
the capacity for glomerular ﬁltration. Collecting duct-like
structures appear to extend from the transplant toward the
papilla of the host. Although there is no direct evidence
that these collecting duct-like structures connect with the
host’s collecting system or that the transplant functions in
a manner similar to that of a native kidney, the results
provide a rationale for the existence of renal stem cells
in the metanephros from early embryos, which may be
a potential source of transplantable regenerated kidney.
P o t e n t i a lp r o b l e m sw i t ht h i ss y s t e mi n c l u d eq u e s t i o n sa s
to the suitability of the renal capsule of dialysis patients
as a transplant site, given the signiﬁcant disruptions to
this area, including the vasculature, and the fact that space
limitations beneath the renal capsule may hinder the growth
of transplants. These concerns may be overcome by the
system established by Rogerset al. [9]. These researchers also
used the metanephros as a source of transplantable artiﬁcial
kidney but transplanted the graft into a host omentum,
which is not conﬁned by a tight organ capsule or disturbed
by dialysis. Metanephroi from rat, mouse, and pig were
implanted into the omenta of the rat or mouse, and the
success of transplanting across xenogeneic barriers and the
extent of diﬀerentiation into a functional nephron were
evaluated. This experiment was based on previous studies
showing minimal immunogenicity in tissues harvested at
earlier gestational stages, including the metanephros [10].
In cases of allotransplantation (rat metanephros to rat
omentum), transplants assumed a kidney-like shape in situ
that was approximately one-third the diameter of the native
kidney. Histologically speaking, the transplants contained
well-diﬀerentiated kidney structures. It is important to
note that this transplantation technique can be performed
without immunosuppression. With xenotransplantation, the
pig metanephros grew and diﬀerentiated into renal tissue
in the rat omentum, showing glomeruli, proximal tubules,
and collecting ducts; however, immunosuppressants were
required because without these agents the transplants dis-
appeared soon after transplantation. What is interesting is
that the graft pig metanephros was slightly larger in volume
(diameter and weight) as compared to that of a normal rat
kidney. Furthermore, the transplanted tissue produced urine
and, surprisingly, after intact ureteroureterostomy with the
ureter of the kidney that was removed, anephric rats started
to void and showed a prolonged lifespan [11]. This success
holds the promise of a new and practical therapeuticstrategy
for kidney disease in which a functional renal unit can be
established by implanting xenometanephros together with
immunosuppression.
Recently, Osafune et al. reported an in vitro culture
system in which a single Sall1 highly expressing cell from
the metanephric mesenchyme forms a 3D kidney structure
consisting ofglomeruliandrenal tubules[12].More recently,
Unbekandt and Davies reported that single-cell suspensions
dissociated from metanephros can reaggregate to form a
organotypic renal structure if they are treated with an
inhibitor of Rho-associated kinase [13]. These systems
are useful for examining mechanisms of renal progenitor
diﬀerentiation and suggest the possibility of developing a
whole kidney from a single stem cell.
3.KidneyRegenerationUsing
ArtiﬁcialScaffolding
One possible means of creating an optimal niche for
pluripotent stem cells to diﬀerentiate into a kidney is to
provide an artiﬁcial scaﬀold upon which the stem cells can
function. This strategy was used recently by Ott et al. [14]
to successfully develop a functional artiﬁcial rat heart using
a cadaveric heart as the artiﬁcial scaﬀold. A whole-heart
scaﬀoldwith intact3Dgeometry andvasculature wascreated
by coronary perfusion with detergents into the cadaveric
heart. This decellularized heart was then repopulated with
neonatal cardiac cells or rat aortic endothelial cells and
cultured under physiological conditions to simulate organ
maturation [14]. The injected neonatal cardiac cells formed
a contractile myocardium, which performed the stroke
function.
Cadaveric scaﬀolds have also been used to develop
transplantable liver and lung using mature hepatocyte and
alveolar epithelial cells, respectively [15, 16]. After trans-
plantation of the recellularized grafts, they were successfully
functioning as a hepatocyte and gas exchanger. Such an
approach is promising for regenerating organs that have a
simple architecture. However, pluripotent stem cells should
be used if this technique is used for kidney regeneration,
because the kidney is composed of multiple cell types,
such as tubular epithelial cells and glomerular cells. For
this purpose, experts should know which stem cells may
selectivelydiﬀerentiateintokidneyresidentialcells.Onesuch
candidate is embryonic stem (ES) cells.
ES cells are undiﬀerentiated pluripotent stem cells
isolated from the inner cell mass of blastocysts [17]. ES
cells can diﬀerentiate into several cell types of mesodermal,
endodermal, and ectodermal lineages, depending on culture
conditions. Because human ES cells can diﬀerentiate into
kidney structures when injected into immunosuppressed
mice [18, 19], studies have focused on identifying the precise
culture conditions that allow the diﬀerentiation of ES cells
into renal cells in vitro. To this end, Schuldiner et al. [20]
showed that human ES cells cultured with 8 growth factors,International Journal of Nephrology 3
including hepatocyte growth factor (HGF) and activin A,
diﬀerentiated into cells expressing WT-1 and renin [19].
More recently, mouse ES cells stably transfected with Wnt4
(Wnt4-ES cells) were diﬀerentiated into tubular structures
expressing AQP-2 in the presence of HGF and activin A [21].
An ex vivo culture system in which ES cells (or ES-derived
cells) were cultured in the developing metanephros was also
investigated to determine the capacity of ES cells to diﬀer-
entiate into kidney cells integrated into the kidney structure
[22]. ROSA26 ES cells were stimulated with developmental
signals in the microenvironment of a developing kidney
following injection into a metanephros cultured in vitro.
ES cell-derived, β-galactosidase-positive cells were identiﬁed
in epithelial structures resembling renal tubules with an
eﬃciency approaching 50% [22]. Based on these results,
Kim and Dressler [23] attempted to identify the nephrogenic
growth factors needed to induce diﬀerentiation of ES cells
into renal epithelial cells. When injected into a developing
metanephros, ES cells treated with retinoic acid, activin A,
and BMP7 contributed to tubular epithelia with near 100%
eﬃciency [23]. Furthermore, Vigneau et al. [24]s h o w e d
that ES cells expressing brachyury, a marker of mesoderm
speciﬁcation, became a renal progenitor population in the
presence of activin A. After injection into a developing
metanephros, these cells might be incorporated into the
blastema cells of the nephrogenic zone. In addition, a single
injection of the same cells into developing live newborn
mouse kidneys saw them stably integrated into proximal
tubules with normal morphology and polarization for 7
months without teratoma formation [24]. Taken together,
these data highlight ES cells as a potential source of renal
stem cells to be diﬀerentiated into renal-resident cells.
Based on this series of studies, Ross and coworkers
attempted recently to regenerate an entire kidney using a
decellularized cadaveric kidney scaﬀold [25]. After decel-
lularization, murine ES cells were infused via the renal
artery and were found to localize to the vasculature and
glomeruli, with subsequent migration into the tubules.
Immunohistochemical analysis suggested that the infused
cells had diﬀerentiated into mature kidney cells. Although
renal function is yet to be examined, this approach may be
useful for the production of an entire kidney.
To address the adverse eﬀects of immunosuppressants,
Lanza et al. [26] attempted to develop a self-kidney unit to
eliminate the immune response problem and, therefore, the
need forimmunosuppression. To generate a histocompatible
kidney for artiﬁcial organ transplantation, Lanza et al.
[26] used a nuclear transplantation technique in which
dermal ﬁbroblasts isolated from adult cow were transferred
into enucleated bovine oocytes and then transferred non-
surgically into progestin-synchronized recipients. After 6-7
weeks, metanephroi were isolated from embryos, digested
using collagenase, and expanded until the desired cell
number was obtained by culture in vitro. These cells were
then seeded onto a specialized polymer tube, followed by
implantation into the same cow from which the cells had
been cloned. What is striking is that this renal device seeded
with cloned metanephric cells appeared to produce a urine-
like liquid, whereas those without cells or those seeded with
allogeneic cells did not. Histological analysis of the explant
revealed a well-developed renal structure composed of orga-
nized glomeruli-like,tubule-like,vascularelementsthatwere
clearly distinct from one another but continuous within the
structure. Therefore, these renal tissues appeared integrally
connected in a unidirectional manner to the reservoirs,
resulting in the excretion of urine into the collecting system.
Although it is not clear how the cultured cells digested
from the metanephros gained polarity and self-assembled
into glomeruli and tubules, this technique successfully used
nuclear transplantation for renal regeneration without the
risks and long-term eﬀects of immunosuppression.
4.De Novo KidneyRegenerationUsing
Blastocyst Complementation
It was previously reported that injection of normal ES
cells into the blastocysts of recombination-activating gene
2 (RAG-2)-deﬁcient mice, which have no mature B or
T lymphocytes, generated somatic chimeras with ES cell-
derived mature B and T cells [27]. This blastocyst comple-
mentation system was recently applied to reconstructing the
entire human kidney. Injection of wild-type ES cells into
the blastocysts of Sall1-null mice, which lack kidneys, gen-
erated metanephroi composed exclusively of ES cell-derived
diﬀerentiated cells. This strategy, however, was assessed
to be unsuitable for human clinical application, because
it is quite diﬃcult to generate interspeciﬁc chimeras in
livestock. Many groups have sought to generate interspeciﬁc
chimeras between mouse and rat, achieving success with
chimeric preimplantation embryos in vitro but failing with
live chimeric animals [28, 29]. Extraembryonic lineage cells
like trophectoderm, derived from xenogenic embryos, may
suﬀer from inhibition of implantation on exposure to the
host uterus, suggesting that only cells of preblastocyst origin
can contribute to the extraembryonic lineage cells. In this
context, thediscovery of inducedpluripotentstem (iPS)cells
allayed this concern.
iPS cells were produced by Takahashi and Yamanaka
[30] from cultured somatic cells by retroviral transfer with
Oct3/4, Sox2, c-Myc, and Klf4, which are transcription fac-
tors associated with pluripotency [31]. Rate-reprogrammed
iPS cells were subsequently derived by the reactivation of
Fbx15 [31], Oct4 [31], or Nanog [32], all of which carry a
drug resistance marker inserted into the respective endoge-
nous locus by homologous recombination or a transgene
containing the Nanog promoter. Furthermore, iPS cells were
also isolated based on their ES-like morphology, without
the use of transgenic donor cells [33], and the therapeutic
potential of autologous iPS cells in a mouse model of a
hereditary disease has been reported [34]. Recently, human
iPScellsweresuccessfully inducedfromadultskinﬁbroblasts
using the same 4 factors as detailed above [35]. iPS cells
are epigenetically and biologically indistinguishable from
normal ES cells, and, therefore, it is suggested that they
be used to produce interspeciﬁc chimeras. Kobayashi and
coworkers recently reported successful regeneration of rat
pancreas in mouse via an interspeciﬁc blastocyst injection4 International Journal of Nephrology
of iPS cells [36]. They injected rat iPS cells into Pdx-1−/−
(pancreatogenesis-disabled) mouse blastocysts and found
thatthenewbornchimera ofratandmouse processedalmost
entirely iPS-derived pancreas. This success proves that when
an empty developmental niche for an organ is provided
(as with the Pdx1−/− m o u s ea n dt h ep a n c r e a t i cn i c h e ) ,i P S
cell-derived cellular progeny can occupy that niche and can
compensate developmentally for the missing contents of
the niche, forming a complicated organ composed almost
entirely of cells derived from donor iPS cells even if the
blastocyte complementation involves diﬀerent species.
Furthermore, instead of tetraploid complementation,
Espejel and coworkers generated chimeric mice that
experienced progressive liver repopulation with iPS cell-
derived hepatocytes postnatally using blastocytes deﬁcient
in fumarylacetoacetate hydrolase [37]. The entire liver was
composed of iPS cell-derived hepatocytes by the time
the mice reached adulthood. They replicated the unique
proliferative capabilities of normal hepatocytes and were
able to regenerate liver after transplantation and two-thirds
partial hepatectomy. These successes strongly suggest that
blastocyst complementation is one of the most promising
strategiesforregeneratingthekidney.However,thesesystems
are not available for clinical use at this time, because it is
not possible to generate the vascular and nervous systems.
In addition, the more important ethical issues involved with
manipulating blastocysts with iPS cells remain unresolved.
Nonetheless, this success highlights the rationale that the
eventual clinical application of kidney regeneration must
depend on developmental programming.
5.De Novo KidneyRegenerationUsing
GrowingXenoembryos
We attempted to develop an entire kidney using scaﬀolding
from mesenchymal stem cells (MSCs). It has been shown
that MSCs have the capacity for site-speciﬁc diﬀerentiation
into various cell types of mesodermal lineage, including
chondrocytes, adipocytes, myocytes, cardiomyocytes, bone
marrow stromal cells, and thymic stromal cells [38, 39];
this suggests that they may also diﬀerentiate into kidney
residential cells.
Initially, we tried to reconstruct an organized and
functional kidney structure using a developing heterozoic
embryoasan“organfactory.”Duringembryogenesis,asingle
fertilized cell develops into a whole body within 266 (for
h u m a n s )o r2 0d a y s( f o rr o d e n t s ) .T h i sn e o n a t eh a se v e r y
organ positioned correctly, indicating that a single fertilized
ovum contains a blueprint from which the body, including
the kidney, can be built. Therefore, we sought to “borrow”
this programming of a developing embryo by applying the
stem cells at the niche of organogenesis.
During developmentof the metanephros, the metaneph-
ric mesenchyme initially forms from the caudal portion
of the nephrogenic cord [40] and secretes glial cell line-
derived neurotrophic factor (GDNF), which induces the
nearby Wolﬃan duct to produce a ureteric bud [41].
The metanephric mesenchyme consequently forms the
glomerulus, proximal tubule, loop of Henle, and distal
tubule, as well as the interstitium, as a result of reciprocal
epithelial-mesenchymal induction between the ureteric bud
and metanephric mesenchyme [42]. For this epithelial-
mesenchymal induction to occur, GDNF must interact with
its receptor, c-ret, which is expressed in the Wolﬃan duct
[42]. We hypothesized that GDNF-expressing MSCs may
diﬀerentiate into kidney structures if positioned at the
budding site and stimulated by numerous factors spatially
andtemporallyidenticaltothosefoundinthedevelopmental
milieu.
To investigate this hypothesis, we initially injected
humanmesenchymal stemcells(hMSCs)intothedeveloping
metanephros in vitro, although this was not suﬃcient to
achievekidneyorganogenesis [43].This suggests that hMSCs
must be placed before the metanephros begins to develop in
a speciﬁc, deﬁned embryonic niche to allow their exposure
to the repertoire of nephrogenic signals required to generate
the organ. This can be best achieved by implanting hMSCs
into the nephrogenic site of a developing embryo. Therefore,
we establishedaculturesystemincombinationwithawhole-
embryo culture system, followed by metanephric organ cul-
ture (Figure 1). This “relay culture” allows the development
of the metanephros from structures present before budding
until the occurrence of complete organogenesis ex utero.
In this system, embryos were isolated from the mother
before budding and were grown in a culture bottle until
the formation of a rudimentary kidney so that it could be
further developed by organ culture in vitro [43]. Using this
combination, rudimentary kidneys continued to grow in
vitro, as assessed by the observation of ﬁne tubulogenesis
and ureteric bud branching, indicating that the metanephros
can ﬁnish developingex utero evenif the embryo is dissected
prior to sprouting of the ureteric bud.
Based on these results, hMSCs were microinjected
at the site of budding and subjected to relay culture.
Before injection, the hMSCs were genetically engineered
to express GDNF temporally using adenovirus and were
labeled with the LacZ gene and dioctadecyl-3,3,3
 ,3
 -
tetramethylindocarbocyanine. Viral free manipulation can
also be performed using thermoreversible GDNF polymer
[44]. Soon after injection, the embryos, together with
the placenta, were transferred to the incubator for whole
embryos. After the relay culture, X-gal-positive cells were
scattered throughout the rudimentary metanephros and
were morphologically identical to tubular epithelial cells,
interstitial cells, and glomerular epithelial cells [43]. In
addition, reverse transcription-polymerase chain reaction
revealed the expression of several podocyte- and tubule-
speciﬁc genes [43]. These data demonstrated that using
a xenobiotic developmental process for growing embryos
allows endogenous hMSCs to undergo an epithelial con-
version and be transformed into an orchestrated nephron
consisting of glomerular epithelial cells (podocytes) and
tubular epithelial cells that are linked. hMSCs can also
diﬀerentiate into renal stroma after renal development [43].
We then examined the next issue in the successful devel-
opment of an artiﬁcial kidney de novo: urine production.
This requires that the kidney formed have the vascularInternational Journal of Nephrology 5
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Figure 1: Strategy for nephron regeneration. MSCs were injected at the site of sprouting of the ureteric bud of E11.5 rat embryo (a). These
embryos were developed in the whole-embryo culture system (b) for 48 hours. Embryos developed in this system shows the continuation of
development in this system ((c): arrow, yolk sac; asterisk, placenta).
Neokidney Original kidney
Desmin+ mesangium cells
Synaptopodin+ podocytes
Figure 2: Development of neokidney derived from hMSCs. Kidney anlagen derived from MSCs was transplanted into rat omentum. After
this relay culturing, hMSCs formed into neokidney in the rat omentum.Histological analysis revealed a well-diﬀerentiated kidney structure
(right panels). Desmin-positive mesangial cells and synaptopodin-positive podocytes can be seen (right panels).
system of the recipient; therefore, the primary system
must be modiﬁed to allow for vascular integration from
the recipient to form a functional nephron. We used the
ﬁndings of Rogers et al. [8] described above, according to
which the metanephros can grow and diﬀerentiate into a
functional renal unit with integration of recipient vessels
if it is implanted into the omentum. We conﬁrmed that
the omentum is a suitable site for vascular integration
by comparing several transplantation sites [45]. We trans-
planted metanephroi from diﬀerent embryonic stages into
theomentumandfound after 2weeksthat onlymetanephroi
from rat embryos older than embryonic day 13.5 developed
successfully. Therefore,therelay culturesystem was modiﬁed
such that organ culture was terminated within 24 hours,
by which time the metanephros was allowed to develop
suﬃciently and the kidney primordia could be transplanted
into the omentum (termed “modiﬁed relay culture system”).
As a result, an hMSC-derived “neo-” kidney was generated
that was equivalent to a human nephron (Figure 2)[ 46].
To examine the origin of the vasculature in the neokid-
ney, we generated LacZ-transgenic rats [47] as recipients
so that donor- and recipient-derived tissues would be dis-
tinguishable by X-gal assay. The usefulness of genetically
marked transgenic (tg) rats in organogenesis has been
conﬁrmed previously, using GFP as a marker, in the rat.
Thus, we chose to use the LacZ tg rat, which expresses
t h em a r k e rg e n eu b i q u i t o u s l y ,t od e t e r m i n et h ev a s c u l a r
origin in our experiments [47]. Using the modiﬁed relay6 International Journal of Nephrology
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Figure 3: Dual step for the development of whole functional kidney.
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Figure 4: Putative scenario for the application of stem cell biology to kidney regeneration. Renal stem cells derived from bone marrow cells
or skin ﬁbroblasts of a dialysis patient are cultured in a growing xenoembryo for a given time to develop into kidney primordia, followed
by their autologous implantation into the omentum of the same patient. Kidney primordia eventually become a self-organ that performs
mature renal functions. The patient may experience relief from dialysis and completely overcome the renal disease.
culture, we found that several vessels from the omentum
appeared to be integrated into the neokidney, and X-gal
staining showed that most of the peritubular capillaries
were LacZ positive, suggesting that they were of recipient
origin. Furthermore, electron microscope analysis revealed
red blood cells in the glomerular vasculature. These data
indicated that the vasculature of the neokidney in the
omentum originated from the host and communicated with
the host circulation, suggesting its viability for collecting
and ﬁltering the host blood to produce urine. To verify
this, we left the neokidney in the omentum for 4 weeks
to develop further. What is surprising is that the structure
developed hydronephrosis, conﬁrming the ability of the
neokidney to produce urine. If the ureters were buried
under the fat of the omentum, the urine would have no
egress, resulting in hydronephrosis. Analysis of the liquid
from the expanded ureter showed higher concentrations of
urea nitrogen and creatinine than the recipient sera in the
native urine. Therefore, we concluded that the neokidney
that developed in the omentum was capable of producing
urine by ﬁltering the recipient’s blood.
Production of erythropoietin (EPO) to maintain ery-
thropoiesis is another important function of the kidney.
EPO stimulates red blood cell production and is producedInternational Journal of Nephrology 7
mainly in the kidneys. We found 3 major ﬁndings regarding
the hMSC-derived neokidney in rats: (i) human EPO is
producedinratsharboring anorganoidderivedfromautolo-
gous human bone marrow cells, (ii) human EPO production
is stimulated by the induction of anemia, suggesting that this
system preserves the normal physiological regulation of EPO
levels, and (iii) levels of EPO generated by the neokidney
in response to anemia in rats in which native EPO was
suppressed are suﬃcient to restore red cell recovery to a rate
similar to that in control rats [48]. Taken together, these data
suggest that the neokidney derived from hMSCs may be able
to fulﬁll all renal functions, includingurine production. This
work could lead to a new generation of therapy modalities
for kidney disease.
As mentioned earlier, kidney is formed by a reciprocal
interaction between the metanephric mesenchyme and the
ureteric buds and is, thus, derived from a collecting system
(such as the ureters and the collecting ducts), which is
a derivative of the ureteric bud, and other components
(such as the glomeruli and tubules, which are derivatives
of the metanephric mesenchyme). Our current system may
regenerate the derivatives of the metanephric mesenchyme
but not the derivatives of the ureteric bud. Concerning this
issue, we assessed whether MSCs are able to diﬀerentiate
into the ureteric bud progenitor; we did this using chick
embryos,whichcanbemoreeasilymanipulatedandcultured
as compared to mammalian embryos [49]. When hMSCs
expressing Pax2 were transplanted into the chicken ureteric
bud progenitor region, they migrated caudally with the
elongating Wolﬃan duct and were integrated into the
Wolﬃan duct epithelia and then expressed LIM1, showing
that they can diﬀerentiate into the Wolﬃan duct cells under
the inﬂuence of local xenosignals [49]. This suggests that
the whole kidney may be rebuilt by transplanting hMSCs at
the suitable time and part for derivatives of the metanephric
mesenchyme and ureteric bud (Figure 3).
Based on our successes, we are currently investigating
the possibility of experimenting on a larger animal, that is,
the pig, because the porcine kidney has almost the same
volume as the human kidney. The ultimate size of the
developed metanephros appears to be imprinted during the
very early stages of development in the host embryo, as
the metanephroi of larger animals transplanted into the
omentaofsmallerhostsdevelopintoorgans oflargervolume
(diameter and weight) as compared to that of a normal
host kidney [50]. We hope that this system will facilitate the
development of larger organs that are more suitable for use
in humans (Figure 4).
6.Conclusion
In this article, we reviewed recent research on using renal
stemcellstotreatkidneydiseasesandproposedtheirpossible
applicationinkidneyregeneration.Weknowthatpriortothe
total loss of renal structure, kidney function can be restored
by reactivating quiescent renal stem cells and/or supplying
renal stem cells expandedsuﬃciently invitro. Suchstemcells
may contribute to kidney regeneration, leading to recovery
from organ failure.
We believe that emerging knowledge of kidney stem cell
biology and developmental biology will enable the develop-
ment of new therapeutic strategies for kidney regeneration
that aim to regain damaged components of the kidney or
restore kidney function.
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